SFA-OPEX consolidation US Oncology

Janssen Biotech, Inc., a member of Johnson & Johnson’s Family of Companies, is recruiting for a Senior Financial Analyst. The position will support the Oncology commercial franchise budgets within Janssen Biotech, Inc.  This position will be located in Horsham, PA and may require occasional travel of up to 10% to the Titusville, NJ location.

At the Janssen Pharmaceutical Companies of Johnson & Johnson, what matters most is helping people live full and healthy lives. We focus on treating, curing, and preventing some of the most devastating and complex diseases of our time. Janssen provides medicines for an array of health concerns in several therapeutic areas. Please visit www.JanssenPharmaceuticalsInc.com for more information. We are Janssen. Our mission drives us. Our patients encourage us. We collaborate with the world for the health of everyone in it.

Within the US Oncology business, our mission is to redefine cancer care by delivering outstanding and accessible therapeutic solutions that prolong and improve patients’ lives.

We grow with a diverse company culture, celebrating the uniqueness of our employees and are committed to inclusion. We are proud to be an equal opportunity employer.

Responsibilities:

The Senior Financial Analyst will provide key business support, strategic analysis, reporting and consolidation for Commercial Oncology operating expenses. This is a critical and highly visible role with significant opportunities to present to senior management including Oncology Leadership Team and various business leaders within the organization. The role requires a high level of motivation and the ability to perform under tight turnarounds with limited direct supervision.

• Lead the Financial Planning Cycles, Reporting, and OPEX Analytics for US Oncology
• Responsible for budgeting and managing actual expenses for ~$0.5B in Commercial OPEX across Selling, Medical Affairs (MAF) and Marketing Management organizations
• Responsible for consolidation of Total Oncology Portfolio (inclusive of BMEs for Key JNJ assets DARZALEX, IMBRUVICA, CARVKYTI, TECVAYLI, and ERLEADA) results and all key submissions to NA Finance team
• Form relationships with key partners across the Oncology business, including the VPs of Selling & Marketing, VPs of MAF and their extended teams
• Collaborate across the portfolio to develop and track strategic investment forecasts.
• Influence cross-functional partners regarding investment decisions to drive value and deliver results
• Own ad-hoc analyses and develop executive framing
• Identify process improvements and provide recommendations on key focus areas